RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE
The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such as lung disease (e.g., idiopathic pulmonary fibrosis), kidney d...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SU, Shun PINTO, Donald J.P SHAW, Scott A PABBISETTY, Kumar Balashanmuga MYERS, Michael C MATHUR, Arvind LI, Jianqing |
| description | The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such as lung disease (e.g., idiopathic pulmonary fibrosis), kidney disease (e.g., chronic kidney disease), or hepatic disease (e.g., non-alcoholic steatohepatitis and portal hypertension).
L'invention concerne des composés de Formule (I), qui sont des agonistes du récepteur RXFP1, des compositions les contenant, et des procédés d'utilisation de ceux-ci, par exemple, dans le traitement d'une insuffisance cardiaque, de maladies fibrotiques et de maladies associées telles que la maladie pulmonaire (par exemple, la fibrose pulmonaire idiopathique), une maladie rénale (par exemple, une maladie rénale chronique), ou une maladie hépatique (par exemple, une stéatohépatite non alcoolique et une hypertension portale). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023077041A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023077041A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023077041A13</originalsourceid><addsrcrecordid>eNrjZDAOinALMFTw9XcJ9XEM8Q8KVnDzD1II8XBVCAlydQzxdfULUfB3U_BwdQwKUXBz9PQJDXLlYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkbGBubmBiaGjobGxKkCADQOJ-Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE</title><source>esp@cenet</source><creator>SU, Shun ; PINTO, Donald J.P ; SHAW, Scott A ; PABBISETTY, Kumar Balashanmuga ; MYERS, Michael C ; MATHUR, Arvind ; LI, Jianqing</creator><creatorcontrib>SU, Shun ; PINTO, Donald J.P ; SHAW, Scott A ; PABBISETTY, Kumar Balashanmuga ; MYERS, Michael C ; MATHUR, Arvind ; LI, Jianqing</creatorcontrib><description>The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such as lung disease (e.g., idiopathic pulmonary fibrosis), kidney disease (e.g., chronic kidney disease), or hepatic disease (e.g., non-alcoholic steatohepatitis and portal hypertension).
L'invention concerne des composés de Formule (I), qui sont des agonistes du récepteur RXFP1, des compositions les contenant, et des procédés d'utilisation de ceux-ci, par exemple, dans le traitement d'une insuffisance cardiaque, de maladies fibrotiques et de maladies associées telles que la maladie pulmonaire (par exemple, la fibrose pulmonaire idiopathique), une maladie rénale (par exemple, une maladie rénale chronique), ou une maladie hépatique (par exemple, une stéatohépatite non alcoolique et une hypertension portale).</description><language>eng ; fre</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230504&DB=EPODOC&CC=WO&NR=2023077041A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230504&DB=EPODOC&CC=WO&NR=2023077041A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SU, Shun</creatorcontrib><creatorcontrib>PINTO, Donald J.P</creatorcontrib><creatorcontrib>SHAW, Scott A</creatorcontrib><creatorcontrib>PABBISETTY, Kumar Balashanmuga</creatorcontrib><creatorcontrib>MYERS, Michael C</creatorcontrib><creatorcontrib>MATHUR, Arvind</creatorcontrib><creatorcontrib>LI, Jianqing</creatorcontrib><title>RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE</title><description>The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such as lung disease (e.g., idiopathic pulmonary fibrosis), kidney disease (e.g., chronic kidney disease), or hepatic disease (e.g., non-alcoholic steatohepatitis and portal hypertension).
L'invention concerne des composés de Formule (I), qui sont des agonistes du récepteur RXFP1, des compositions les contenant, et des procédés d'utilisation de ceux-ci, par exemple, dans le traitement d'une insuffisance cardiaque, de maladies fibrotiques et de maladies associées telles que la maladie pulmonaire (par exemple, la fibrose pulmonaire idiopathique), une maladie rénale (par exemple, une maladie rénale chronique), ou une maladie hépatique (par exemple, une stéatohépatite non alcoolique et une hypertension portale).</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAOinALMFTw9XcJ9XEM8Q8KVnDzD1II8XBVCAlydQzxdfULUfB3U_BwdQwKUXBz9PQJDXLlYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkbGBubmBiaGjobGxKkCADQOJ-Y</recordid><startdate>20230504</startdate><enddate>20230504</enddate><creator>SU, Shun</creator><creator>PINTO, Donald J.P</creator><creator>SHAW, Scott A</creator><creator>PABBISETTY, Kumar Balashanmuga</creator><creator>MYERS, Michael C</creator><creator>MATHUR, Arvind</creator><creator>LI, Jianqing</creator><scope>EVB</scope></search><sort><creationdate>20230504</creationdate><title>RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE</title><author>SU, Shun ; PINTO, Donald J.P ; SHAW, Scott A ; PABBISETTY, Kumar Balashanmuga ; MYERS, Michael C ; MATHUR, Arvind ; LI, Jianqing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023077041A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SU, Shun</creatorcontrib><creatorcontrib>PINTO, Donald J.P</creatorcontrib><creatorcontrib>SHAW, Scott A</creatorcontrib><creatorcontrib>PABBISETTY, Kumar Balashanmuga</creatorcontrib><creatorcontrib>MYERS, Michael C</creatorcontrib><creatorcontrib>MATHUR, Arvind</creatorcontrib><creatorcontrib>LI, Jianqing</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SU, Shun</au><au>PINTO, Donald J.P</au><au>SHAW, Scott A</au><au>PABBISETTY, Kumar Balashanmuga</au><au>MYERS, Michael C</au><au>MATHUR, Arvind</au><au>LI, Jianqing</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE</title><date>2023-05-04</date><risdate>2023</risdate><abstract>The disclosure relates to compounds of Formula (I), which are RXFP1 receptor agonists, compositions containing them, and methods of using them, for example, in the treatment of heart failure, fibrotic diseases, and related diseases such as lung disease (e.g., idiopathic pulmonary fibrosis), kidney disease (e.g., chronic kidney disease), or hepatic disease (e.g., non-alcoholic steatohepatitis and portal hypertension).
L'invention concerne des composés de Formule (I), qui sont des agonistes du récepteur RXFP1, des compositions les contenant, et des procédés d'utilisation de ceux-ci, par exemple, dans le traitement d'une insuffisance cardiaque, de maladies fibrotiques et de maladies associées telles que la maladie pulmonaire (par exemple, la fibrose pulmonaire idiopathique), une maladie rénale (par exemple, une maladie rénale chronique), ou une maladie hépatique (par exemple, une stéatohépatite non alcoolique et une hypertension portale).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023077041A1 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | RXFP1 MODULATORS FOR THE TREATMENT OF HEART FAILURE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A02%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SU,%20Shun&rft.date=2023-05-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023077041A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |